Table 1 DDR1 expression in gastric cancer tissues according to various clinicopathological features
From: Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma
| Â | Â | Â | DDR1 | P value | |
|---|---|---|---|---|---|
Variables | Â | Â | Negative | Positive | Â |
|  |  |  | (n=100) | (n = 102) |  |
Age (years old) | <70 | 147 | 70 (47.6%) | 77 (52.4%) | 0.381 |
≥70 | 55 | 30 (54.5%) | 25 (45.5%) | ||
Gender | Male | 140 | 72 (51.4%) | 68 (48.6%) | 0.411 |
Female | 62 | 28 (45.2%) | 34 (54.8%) | ||
Location | Upper | 26 | 12 (46.2%) | 14 (53.8%) | 0.597 |
Middle | 62 | 34 (54.8%) | 28 (45.2%) | ||
Low | 114 | 54 (47.4%) | 60 (52.6%) | ||
Lauren | Intestinal | 99 | 44 (44.4%) | 55 (55.6%) | 0.085 |
Mixed | 33 | 22 (66.7%) | 11 (33.3%) | ||
Diffuse | 70 | 34 (48.6%) | 36 (51.4%) | ||
Differentiation | Differentiated | 70 | 35 (50.0%) | 35 (50.0%) | 0.918 |
Undifferentiated | 132 | 65 (49.2%) | 67 (50.8%) | ||
T stage | T1/T2 | 100 | 58 (58.0%) | 42 (42.0%) | 0.017 |
T3/T4 | 102 | 42 (41.2%) | 60 (58.8%) | ||
N stage | N0/N1 | 125 | 66 (52.8%) | 59 (47.2%) | 0.233 |
N2/N3 | 77 | 34 (44.2%) | 43 (55.8%) | ||
Adjuvant chemotherapy | None | 59 | 32 (54.2%) | 27 (45.8%) | 0.388 |
Yes | 143 | 68 (47.6%) | 75 (52.4%) | ||